Denali Therapeutics shares owned by Capital Research Global Investors
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Capital Research Global Investors
from 13F filings
Historical chart of Capital Research Global Investors investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Capital Research Global Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Capital Research Global Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $112M | 5.5M | 20.38 |
| 2024-09-30 | $230M | 7.9M | 29.13 |
| 2024-03-31 | $124M | 6.0M | 20.52 |
| 2023-12-31 | $62M | 2.9M | 21.46 |
| 2023-09-30 | $59M | 2.9M | 20.63 |
| 2023-06-30 | $84M | 2.8M | 29.51 |
| 2023-03-31 | $57M | 2.5M | 23.04 |
| 2022-12-31 | $63M | 2.3M | 27.81 |
More positions owned by Capital Research Global Investors
View all positions for Capital Research Global Investors